325 related articles for article (PubMed ID: 26788788)
1. Clinical Application of Progesterone for the Prevention of Preterm Birth, 2016.
Goodnight W
Am J Perinatol; 2016 Feb; 33(3):253-7. PubMed ID: 26788788
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of intramuscular versus vaginal progesterone for the prevention of recurrent preterm birth.
Elimian A; Smith K; Williams M; Knudtson E; Goodman JR; Escobedo MB
Int J Gynaecol Obstet; 2016 Aug; 134(2):169-72. PubMed ID: 27168167
[TBL] [Abstract][Full Text] [Related]
3. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
[TBL] [Abstract][Full Text] [Related]
4. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
O'Brien JM; Lewis DF
Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
[TBL] [Abstract][Full Text] [Related]
5. Progestogens for Maintenance Tocolysis in Women With a Short Cervix: A Randomized Controlled Trial.
Facchinetti F; Vergani P; Di Tommaso M; Marozio L; Acaia B; Vicini R; Pignatti L; Locatelli A; Spitaleri M; Benedetto C; Zaina B; DʼAmico R
Obstet Gynecol; 2017 Jul; 130(1):64-70. PubMed ID: 28594783
[TBL] [Abstract][Full Text] [Related]
6. The association of different progesterone preparations with preterm birth prevention.
Krispin E; Hadar E; Chen R; Wiznitzer A; Kaplan B
J Matern Fetal Neonatal Med; 2019 Oct; 32(20):3452-3457. PubMed ID: 29699436
[No Abstract] [Full Text] [Related]
7. Meta-analysis of randomized controlled trials comparing 17α-hydroxyprogesterone caproate and vaginal progesterone for the prevention of recurrent spontaneous preterm delivery.
Oler E; Eke AC; Hesson A
Int J Gynaecol Obstet; 2017 Jul; 138(1):12-16. PubMed ID: 28369874
[TBL] [Abstract][Full Text] [Related]
8. Progesterone to prevent spontaneous preterm birth.
Romero R; Yeo L; Chaemsaithong P; Chaiworapongsa T; Hassan SS
Semin Fetal Neonatal Med; 2014 Feb; 19(1):15-26. PubMed ID: 24315687
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis.
Schuit E; Stock S; Rode L; Rouse DJ; Lim AC; Norman JE; Nassar AH; Serra V; Combs CA; Vayssiere C; Aboulghar MM; Wood S; Çetingöz E; Briery CM; Fonseca EB; Worda K; Tabor A; Thom EA; Caritis SN; Awwad J; Usta IM; Perales A; Meseguer J; Maurel K; Garite T; Aboulghar MA; Amin YM; Ross S; Cam C; Karateke A; Morrison JC; Magann EF; Nicolaides KH; Zuithoff NP; Groenwold RH; Moons KG; Kwee A; Mol BW;
BJOG; 2015 Jan; 122(1):27-37. PubMed ID: 25145491
[TBL] [Abstract][Full Text] [Related]
10. 17-alpha-hydroxyprogesterone caproate versus vaginal progesterone suppository for the prevention of preterm birth in women with a sonographically short cervix: A randomized controlled trial.
Pirjani R; Heidari R; Rahimi-Foroushani A; Bayesh S; Esmailzadeh A
J Obstet Gynaecol Res; 2017 Jan; 43(1):57-64. PubMed ID: 27775195
[TBL] [Abstract][Full Text] [Related]
11. Treatment options and recommendations to reduce preterm births in women with short cervix.
Slager J; Lynne S
J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244
[TBL] [Abstract][Full Text] [Related]
12. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
Manuck TA; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Varner MW; Andrews W; Saade G; Sadovsky Y; Reddy UM; Ilekis J;
Am J Obstet Gynecol; 2016 Mar; 214(3):376.e1-8. PubMed ID: 26692181
[TBL] [Abstract][Full Text] [Related]
13. 17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial.
Winer N; Bretelle F; Senat MV; Bohec C; Deruelle P; Perrotin F; Connan L; Vayssière C; Langer B; Capelle M; Azimi S; Porcher R; Rozenberg P;
Am J Obstet Gynecol; 2015 Apr; 212(4):485.e1-485.e10. PubMed ID: 25448515
[TBL] [Abstract][Full Text] [Related]
14. Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety.
El-Refaie W; Abdelhafez MS; Badawy A
Arch Gynecol Obstet; 2016 Jan; 293(1):61-67. PubMed ID: 26044148
[TBL] [Abstract][Full Text] [Related]
15. [First year experience using arabin cervical pessary with intravaginal micronized progesterone for the prevention of preterm birth in patients with mid-trimester short cervix].
Zimerman AL; Neeman O; Wiener Y; Maymon R; Arie H
Harefuah; 2014 Feb; 153(2):79-82, 127. PubMed ID: 24716423
[TBL] [Abstract][Full Text] [Related]
16. Vaginal progesterone in women with twin gestations complicated by short cervix: a retrospective cohort study.
Brubaker SG; Pessel C; Zork N; Gyamfi-Bannerman C; Ananth CV
BJOG; 2015 Apr; 122(5):712-8. PubMed ID: 25428801
[TBL] [Abstract][Full Text] [Related]
17. Effect of 17-alpha hydroxyprogesterone caproate on cervical length in twin pregnancies.
Lim AC; Schuit E; Papatsonis D; van Eyck J; Porath MM; van Oirschot CM; Hummel P; Hasaart TH; Kleiverda G; de Graaf IM; van Ginkel AA; Mol BW; Bruinse HW
Ultrasound Obstet Gynecol; 2012 Oct; 40(4):426-30. PubMed ID: 23008102
[TBL] [Abstract][Full Text] [Related]
18. A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix.
Romero R; Yeo L; Miranda J; Hassan SS; Conde-Agudelo A; Chaiworapongsa T
J Perinat Med; 2013 Jan; 41(1):27-44. PubMed ID: 23314512
[TBL] [Abstract][Full Text] [Related]
19. Management of Short Cervix during Pregnancy: A Review.
Gilner J; Biggio J
Am J Perinatol; 2016 Feb; 33(3):245-52. PubMed ID: 26788787
[TBL] [Abstract][Full Text] [Related]
20. Intramuscular progesterone in women with twins and a prior singleton spontaneous preterm birth.
Ward A; Greenberg V; Valcarcel B; Boelig RC; Al-Kouatly HB; Berghella V
Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100124. PubMed ID: 33345870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
